UPNANO GMBH
Desconocido
INCITE: Immune Niches for Cancer ImmunoTherapy Enhancement
UPNANO GMBH
participó en un
H2020:
H2020-FETOPEN-2018-2020
Cancer is rapidly becoming the most frequent cause of morbidity and mortality in the EU, accounting for a quarter of all deaths in EU. Witho...
2020-12-21 - 2025-04-30 | Financiado
2020-12-21 - 2025-04-30 | Financiado
* No se disponen de datos de la empresa actual.